Keymed Biosciences Statistics

Total Valuation

HKG:2162 has a market cap or net worth of HKD 11.12 billion. The enterprise value is 9.63 billion.

Market Cap	11.12B
Enterprise Value	9.63B

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2162 has 275.60 million shares outstanding. The number of shares has increased by 0.22% in one year.

Current Share Class	275.60M
Shares Outstanding	275.60M
Shares Change (YoY)	+0.22%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	25.24%
Float	184.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.41
PB Ratio	4.22
P/TBV Ratio	4.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.56
EV / Sales	21.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.07

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.30.

Current Ratio	3.30
Quick Ratio	3.04
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-0.76
Interest Coverage	-33.92

Financial Efficiency

Return on equity (ROE) is -18.85% and return on invested capital (ROIC) is -11.80%.

Return on Equity (ROE)	-18.85%
Return on Assets (ROA)	-10.23%
Return on Invested Capital (ROIC)	-11.80%
Return on Capital Employed (ROCE)	-20.74%
Revenue Per Employee	362,160
Profits Per Employee	-435,855
Employee Count	1,258
Asset Turnover	0.11
Inventory Turnover	0.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.03
52-Week Price Change	n/a
50-Day Moving Average	40.81
200-Day Moving Average	37.16
Relative Strength Index (RSI)	44.17
Average Volume (20 Days)	1,993,092

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2162 had revenue of HKD 455.60 million and -548.31 million in losses. Loss per share was -2.09.

Revenue	455.60M
Gross Profit	442.61M
Operating Income	-666.26M
Pretax Income	-541.29M
Net Income	-548.31M
EBITDA	-586.44M
EBIT	-666.26M
Loss Per Share	-2.09

Full Income Statement

Balance Sheet

The company has 2.29 billion in cash and 801.58 million in debt, giving a net cash position of 1.49 billion or 5.41 per share.

Cash & Cash Equivalents	2.29B
Total Debt	801.58M
Net Cash	1.49B
Net Cash Per Share	5.41
Equity (Book Value)	2.63B
Book Value Per Share	9.56
Working Capital	1.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -840.31 million and capital expenditures -221.26 million, giving a free cash flow of -1.06 billion.

Operating Cash Flow	-840.31M
Capital Expenditures	-221.26M
Free Cash Flow	-1.06B
FCF Per Share	-3.85

Full Cash Flow Statement

Margins

Gross margin is 97.15%, with operating and profit margins of -146.24% and -120.35%.

Gross Margin	97.15%
Operating Margin	-146.24%
Pretax Margin	-118.81%
Profit Margin	-120.35%
EBITDA Margin	-128.72%
EBIT Margin	-146.24%
FCF Margin	n/a

Dividends & Yields

HKG:2162 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.22%
Shareholder Yield	-0.22%
Earnings Yield	-4.93%
FCF Yield	-9.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2162 has an Altman Z-Score of 2.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.06
Piotroski F-Score	n/a